Vision Loss In Optic Nerve Sheath Meningiomas Reduced By Fractionated Stereotactic Radiotherapy

Links shared publicly online about this topic.

1,627
total visits

Vision Loss In Optic Nerve Sheath Meningiomas Reduced By Fractionated Stereotactic Radiotherapy

Optic nerve sheath meningiomas are rare tumors that are traditionally treated with surgery, which is typically a blinding procedure. however, researchers from thomas jefferson university hospital

View full resource at medicalnewstoday.com

Tags: Brain Tumor, Eye, Vision, Hospital, Optics, Hospitals, Jefferson University Hospitals, Surgery

Most Recently Shared on November 4, 2009 at 4:19 pm By:

MNT Cancer News

Vision Loss In Optic Nerve Sheath Meningiomas Reduced By Fractionated Stereotactic Radiotherapy: Optic nerve sh.. http://bit.ly/2cvWD5

3 years ago...

Retweet

Favorite

ASTRO: Stereotactic radiotherapy means less vision loss to optic nerve tumors

healthimaging.com — “The use of fractionated stereotactic radiotherapy (FSR) on patients with optic nerve sheath meningiomas results in less vision loss than when patients are treated with conventional surgery, based on a study presented today at the annual meeting of the American Society for Radiation Oncology in Chicago.” View full resource at healthimaging.com